IBDEI0IA ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8228,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,8228,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,8228,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,8229,0)
 ;;=E89.1^^39^394^31
 ;;^UTILITY(U,$J,358.3,8229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8229,1,3,0)
 ;;=3^Postprocedural Hypoinsulinemia
 ;;^UTILITY(U,$J,358.3,8229,1,4,0)
 ;;=4^E89.1
 ;;^UTILITY(U,$J,358.3,8229,2)
 ;;=^5003036
 ;;^UTILITY(U,$J,358.3,8230,0)
 ;;=R73.03^^39^394^33
 ;;^UTILITY(U,$J,358.3,8230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8230,1,3,0)
 ;;=3^Pre-Diabetes
 ;;^UTILITY(U,$J,358.3,8230,1,4,0)
 ;;=4^R73.03
 ;;^UTILITY(U,$J,358.3,8230,2)
 ;;=^8295662
 ;;^UTILITY(U,$J,358.3,8231,0)
 ;;=E73.9^^39^394^18
 ;;^UTILITY(U,$J,358.3,8231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8231,1,3,0)
 ;;=3^Lactose Intolerance,Unspec
 ;;^UTILITY(U,$J,358.3,8231,1,4,0)
 ;;=4^E73.9
 ;;^UTILITY(U,$J,358.3,8231,2)
 ;;=^5002914
 ;;^UTILITY(U,$J,358.3,8232,0)
 ;;=H40.9^^39^395^11
 ;;^UTILITY(U,$J,358.3,8232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8232,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,8232,1,4,0)
 ;;=4^H40.9
 ;;^UTILITY(U,$J,358.3,8232,2)
 ;;=^5005931
 ;;^UTILITY(U,$J,358.3,8233,0)
 ;;=H26.9^^39^395^7
 ;;^UTILITY(U,$J,358.3,8233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8233,1,3,0)
 ;;=3^Cataract,Unspec
 ;;^UTILITY(U,$J,358.3,8233,1,4,0)
 ;;=4^H26.9
 ;;^UTILITY(U,$J,358.3,8233,2)
 ;;=^5005363
 ;;^UTILITY(U,$J,358.3,8234,0)
 ;;=H10.9^^39^395^10
 ;;^UTILITY(U,$J,358.3,8234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8234,1,3,0)
 ;;=3^Conjunctivitis,Unspec
 ;;^UTILITY(U,$J,358.3,8234,1,4,0)
 ;;=4^H10.9
 ;;^UTILITY(U,$J,358.3,8234,2)
 ;;=^5004716
 ;;^UTILITY(U,$J,358.3,8235,0)
 ;;=H11.32^^39^395^8
 ;;^UTILITY(U,$J,358.3,8235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8235,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,8235,1,4,0)
 ;;=4^H11.32
 ;;^UTILITY(U,$J,358.3,8235,2)
 ;;=^5004783
 ;;^UTILITY(U,$J,358.3,8236,0)
 ;;=H11.31^^39^395^9
 ;;^UTILITY(U,$J,358.3,8236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8236,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,8236,1,4,0)
 ;;=4^H11.31
 ;;^UTILITY(U,$J,358.3,8236,2)
 ;;=^5004782
 ;;^UTILITY(U,$J,358.3,8237,0)
 ;;=H01.002^^39^395^3
 ;;^UTILITY(U,$J,358.3,8237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8237,1,3,0)
 ;;=3^Blepharitis Unspec,Right Lower Eyelid
 ;;^UTILITY(U,$J,358.3,8237,1,4,0)
 ;;=4^H01.002
 ;;^UTILITY(U,$J,358.3,8237,2)
 ;;=^5004239
 ;;^UTILITY(U,$J,358.3,8238,0)
 ;;=H01.004^^39^395^2
 ;;^UTILITY(U,$J,358.3,8238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8238,1,3,0)
 ;;=3^Blepharitis Unspec,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,8238,1,4,0)
 ;;=4^H01.004
 ;;^UTILITY(U,$J,358.3,8238,2)
 ;;=^5004241
 ;;^UTILITY(U,$J,358.3,8239,0)
 ;;=H01.005^^39^395^1
 ;;^UTILITY(U,$J,358.3,8239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8239,1,3,0)
 ;;=3^Blepharitis Unspec,Left Lower Eyelid
 ;;^UTILITY(U,$J,358.3,8239,1,4,0)
 ;;=4^H01.005
 ;;^UTILITY(U,$J,358.3,8239,2)
 ;;=^5133380
 ;;^UTILITY(U,$J,358.3,8240,0)
 ;;=H01.001^^39^395^4
 ;;^UTILITY(U,$J,358.3,8240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8240,1,3,0)
 ;;=3^Blepharitis Unspec,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,8240,1,4,0)
 ;;=4^H01.001
 ;;^UTILITY(U,$J,358.3,8240,2)
 ;;=^5004238
